Stay updated on Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib

Sign up to get notified when there's something new on the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page.
Latest website image capture
Clouds background image

Latest updates to the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    New revision entry (v3.6.6) added to the study history, updating the log to reflect a recent site update.
    Difference
    0.1%
    Check dated 2026-08-31T18:35:48.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The history now shows a newer release revision (v3.6.5) replacing the previous revision (v3.6.4). This reflects a standard site/software update rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-08-10T12:59:04.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The study record history now lists a new revision: v3.6.4, replacing the previous v3.6.3. This indicates a minor system update to the ClinicalTrials.gov record page.
    Difference
    0.1%
    Check dated 2026-07-27T06:39:04.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    New Revision: v3.6.3 appears in the history, replacing the previous v3.6.2 entry. This signifies an update to the study record's metadata.
    Difference
    0.1%
    Check dated 2026-07-05T13:33:49.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    A new revision entry v3.6.2 was added to the study record history. The older revision v3.6.0 was removed from the visible history.
    Difference
    0.1%
    Check dated 2026-06-28T08:22:16.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    Recruitment status changed to 'No longer looking for participants,' indicating enrollment has ended. The record history now shows the latest revision as v3.6.0 and removes the earlier v3.5.5 entry from the history.
    Difference
    0.5%
    Check dated 2026-06-14T01:16:33.000Z thumbnail image

Stay in the know with updates to Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib

Enter your email address, and we'll notify you when there's something new on the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page.